453 related articles for article (PubMed ID: 8951485)
1. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
Moore T; Lee AH
Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
[TBL] [Abstract][Full Text] [Related]
3. Comparison of angiomyofibroblastoma and aggressive angiomyxoma in both sexes: four cases composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets.
Silverman JS; Albukerk J; Tamsen A
Pathol Res Pract; 1997; 193(10):673-82. PubMed ID: 9505259
[TBL] [Abstract][Full Text] [Related]
4. Phyllodes tumors and fibroadenoma common beginning and different ending.
Oprić S; Oprić D; Gugić D; Granić M
Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
[TBL] [Abstract][Full Text] [Related]
5. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
[TBL] [Abstract][Full Text] [Related]
7. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
[TBL] [Abstract][Full Text] [Related]
8. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
Maritz RM; Michelow PM
Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
[TBL] [Abstract][Full Text] [Related]
9. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
10. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
Lee AH; Hodi Z; Ellis IO; Elston CW
Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
[TBL] [Abstract][Full Text] [Related]
11. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
Kocová L; Skálová A; Fakan F; Rousarová M
Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
[TBL] [Abstract][Full Text] [Related]
12. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
13. An unusual soft tissue tumor with features of angiomatoid malignant fibrous histiocytoma composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets. CD34 and factor XIIIa in angiomatoid MFH.
Silverman JS; Lomvardias S
Pathol Res Pract; 1997; 193(1):51-8; discussion 59-60. PubMed ID: 9112273
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
15. Benign phyllodes tumour vs fibroadenoma: FNA cytological differentiation.
Veneti S; Manek S
Cytopathology; 2001 Oct; 12(5):321-8. PubMed ID: 11722512
[TBL] [Abstract][Full Text] [Related]
16. A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype.
Silverman JS; Tamsen A
J Cutan Pathol; 1998 May; 25(5):265-70. PubMed ID: 9696292
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast.
Lee AH
Histopathology; 2008 Jan; 52(1):45-57. PubMed ID: 18171416
[TBL] [Abstract][Full Text] [Related]
18. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
Jacobs TW; Chen YY; Guinee DG; Holden JA; Cha I; Bauermeister DE; Hashimoto B; Wolverton D; Hartzog G
Am J Clin Pathol; 2005 Sep; 124(3):342-54. PubMed ID: 16191502
[TBL] [Abstract][Full Text] [Related]
19. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
20. Phyllodes tumours of the breast - differentiating features in core needle biopsy.
Tsang AK; Chan SK; Lam CC; Lui PC; Chau HH; Tan PH; Tse GM
Histopathology; 2011 Oct; 59(4):600-8. PubMed ID: 21916949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
